Artigo
Recommended Guidelines for Submission, Trimming, Margin Evaluation, and Reporting of Tumor Biopsy Specimens in Veterinary Surgical Pathology
Fecha
2011-01-01Registro en:
Veterinary Pathology. Thousand Oaks: Sage Publications Inc, v. 48, n. 1, p. 19-31, 2011.
0300-9858
10.1177/0300985810389316
WOS:000287200500003
9795829022108105
Autor
Colorado State Univ
IDEXX Reference Labs Inc
Univ Florida
Cornell Univ
Antech Diagnost
Metropolitan Vet Path
Brisbane Vet Specialist Ctr
Universidade Estadual Paulista (Unesp)
University of Guelph
Dept Patol Geral
N Carolina State Univ
Univ Sydney
ARUP Labs
Univ Penn
Free Univ Berlin
Swedish Univ Agr Sci
Univ Georgia
Purdue Univ
Marshfield Labs
Armed Forces Inst Pathol
Angell Anim Med Ctr
Univ Wyoming
Texas A&M Univ
Fac Vet Med
Chulalongkorn Univ
Univ Bologna
Fac Bridge Pathol Ltd
Pfizer Ltd
Univ Illinois
Michigan State University
Royal Vet Coll
Necropsy Serv Grp
Ohio State Univ
VDx Vet Diagnost
Resumen
Neoplastic diseases are typically diagnosed by biopsy and histopathological evaluation. The pathology report is key in determining prognosis, therapeutic decisions, and overall case management and therefore requires diagnostic accuracy, completeness, and clarity. Successful management relies on collaboration between clinical veterinarians, oncologists, and pathologists. To date there has been no standardized approach or guideline for the submission, trimming, margin evaluation, or reporting of neoplastic biopsy specimens in veterinary medicine. To address this issue, a committee consisting of veterinary pathologists and oncologists was established under the auspices of the American College of Veterinary Pathologists Oncology Committee. These consensus guidelines were subsequently reviewed and endorsed by a large international group of veterinary pathologists. These recommended guidelines are not mandated but rather exist to help clinicians and veterinary pathologists optimally handle neoplastic biopsy samples. Many of these guidelines represent the collective experience of the committee members and consensus group when assessing neoplastic lesions from veterinary patients but have not met the rigors of definitive scientific study and investigation. These questions of technique, analysis, and evaluation should be put through formal scrutiny in rigorous clinical studies in the near future so that more definitive guidelines can be derived.